30+
That’s how many years we’ve been investing our research dollars — and our hearts and souls — in Neurology and Oncology R&D.
Brilliant scientists. Advanced technology. Targeted human genetics. Precision chemistry. It all comes together at Eisai to improve health care.
That’s how many years we’ve been investing our research dollars — and our hearts and souls — in Neurology and Oncology R&D.
We're rapidly developing breakthrough solutions to address some of the world's greatest unmet medical needs.
G2D2 combines human genetics, data sciences and precision chemistry to disrupt the traditional drug discovery paradigm.
This science-first organization has one goal: to deliver breakthroughs for dementia patients and their families.
CONTACT G2D2: 35 Cambridgepark Drive, Cambridge, MA 02140, United States |
P: 857.829.6100857.829.6100
EPAT focuses on oncology drug development utilizing our unique Antibody-Drug Conjugate (ADC) technology, bispecifics and other emerging biologics. EPAT’s precision medicine and diagnostics aim to improve therapeutic results with fewer side effects.
CONTACT EPAT: 210 Welsh Pool Road, Exton, PA 19341, United States |
P: 610-423-6100610-423-6100